CVRx, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
CVRX on Nasdaq
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, Minnesota

Insiders trading volume in the past year

CVRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Johnson & Johnson Innovation - JJDC, Inc. 10%+ Owner $64.9 M Sep 15, 2023
New Enterprise Associates 10 L P 10%+ Owner $37.6 M Jul 2, 2021
Geoffrey B. Pardo Director $34 M Jul 2, 2021
Johnson & Johnson 10%+ Owner $21.1 M -$96.1 K -0.45% Feb 16, 2024
GSK plc 10%+ Owner $18.7 M Jul 2, 2021
Nea Partners 10 L P 10%+ Owner $3.22 M Jul 2, 2021
Kevin Hykes PRES & CEO, Director $1.85 M Feb 12, 2024
Robert Allen John Chief Revenue Officer $628 K Jun 27, 2024
Nadim Yared CHIEF EXECUTIVE OFFICER, Director $601 K Feb 2, 2024
John Brintnall Chief Strategy Officer And Sec $585 K Apr 22, 2022
Jared Oasheim Chief Financial Officer $572 K Feb 2, 2024
Joseph P. Slattery Director $551 K Jun 4, 2024
Paul Verrastro Chief Mktg & Strat Officer $407 K -$87 K -17.6% Feb 23, 2024
Ali Behbahani Director $146 K Jun 4, 2024
Kirk G. Nielsen Director $140 K Jun 4, 2024
Martha Shadan Director $140 K Jun 4, 2024
Mudit K. Jain Director $140 K Jun 4, 2024
John M. Nehra Director $139 K Jun 7, 2022
Ding Dean Bruhn Vp Of Reg. Affairs And Qa $30.8 K Aug 2, 2022
Liz Galle Vp Of Global Clinical Research $14.4 K Oct 16, 2023
Craig E. Palmer Svp, U.S. Sales $6.32 K Mar 25, 2024

Recent Insider Transactions by Companies or Individuals for CVRx, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership